Neuromodulators for pain management in rheumatoid arthritis

Background Pain management is a high priority for patients with rheumatoid arthritis (RA). Despite deficiencies in research data, neuromodulators have gained widespread clinical acceptance as adjuvants in the management of patients with chronic musculoskeletal pain. Objectives The aim of this review...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cochrane database of systematic reviews 2012-01, Vol.2012 (3), p.CD008921
Hauptverfasser:	Richards, Bethan L, Whittle, Samuel L, Buchbinder, Rachelle
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Administration, Topical Adult Analgesics Analgesics, Non-Narcotic - adverse effects Analgesics, Non-Narcotic - therapeutic use Analgesics, Non‐Narcotic Arthralgia Arthralgia - drug therapy Arthralgia - etiology Arthritis, Rheumatoid Arthritis, Rheumatoid - complications Arthritis, Rheumatoid - drug therapy Cannabinoids Cannabinoids - adverse effects Cannabinoids - therapeutic use Cannabis Cannabis - chemistry Capsaicin Capsaicin - adverse effects Capsaicin - therapeutic use Chronic non‐cancer pain Depression Depression - drug therapy DMARDS & SAARDS Humans Medicine General & Introductory Medical Sciences Nefopam Nefopam - adverse effects Nefopam - therapeutic use Neurotransmitter Agents Neurotransmitter Agents - adverse effects Neurotransmitter Agents - therapeutic use Pain & anaesthesia Pain Management Pain Management - methods Pharmacological therapies Randomized Controlled Trials as Topic Rheumatoid Arthritis Rheumatology Symptom modifying anti‐rheumatic drugs (SMARDs) Treatment [Pharmacological interventions]
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!